Glorywin Entertainment Group, Inc.
GWIN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$234.73M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $234.73 Million |
|---|---|
| Enterprise Value | $234.73 Million |
| Earnings per Share | $0 |
| Beta | -7.13 |
| Outstanding Shares | 356,194,747 |
Return
| Return on Equity | 16.73% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | 16.73% |
Valuation & Multiples
| P/E Ratio | -26081.37 |
|---|---|
| PEG | 57379.02 |
| Price to Sales | - |
| Price to Book Ratio | -0.66 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -26081.37 |
| Enterprise Value to Net Income | -26082 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Glorywin Entertainment Group, Inc.
0CEO: Sorphea Rath
Glorywin Entertainment Group, Inc. is working on 3D bioprinting technology research and development, and anti-cancer drug research and development. The company was incorporated in 2010 and is based in Denton, Texas.